Eficácia dos regimes de salvamento dose intensificado versus dose padrão na sobrevida livre de progressão em pacientes com linfoma folicular recidivado precoce ou refratário submetidos ao transplante autólogo de células tronco hematopoiéticas: uma revisão sistemática e meta-análise
Loading...
Date
Authors
Mesquita, Felipe Pereira
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Despite substantial advancements in managing follicular
lymphoma, approximately 20% of these patients experience disease
progression within 2 years after induction therapy. These patients exhibit poorer
outcomes, and it has been proposed that autologous bone marrow
transplantation could enhance survival in this context. Little is known about the
ideal rescue chemotherapy regimen. OBJECTIVE: To evaluate the efficacy of
dose-intensified rescue regimens compared to standard dose chemotherapies
in progression free survival among adult patients diagnosed with early relapsed
or primary refractory follicular lymphoma before proceeding to high dose
chemotherapy followed by autologous bone marrow transplantation.
METHODS: This study is in accordance with the Joanna Briggs Institute (JBI)
methodology for effectiveness systematic review and metanalysis. The search
strategy was structured based on the PICO question and tailored to databases
including Medline, Embase, Scopus, Web of Science, Lilacs and Cochrane
Library. The literature search was conducted on May 19, 2023, with no
restrictions on publication date or language. Case reports, case series, review
articles and conference presentations were excluded to ensure data
homogeneity. Initially, studies were screened by title and abstracts. Those
potentially relevant were read in full and assessed against inclusion criteria.
Finally, articles deemed eligible had their data extracted if they reached a
minimum score of 50% in agreement with the JBI Cohort Critical Appraisal Tool
for quality assessment. We used the Cochrane Risk of Bias for Non
Randomized Studies (ROBINS-I) tool in our analysis. The entire process
involved two different researchers, and a third, more experienced researcher
was consulted to resolve any disagreements. This study protocol is registered
on the PROSPERO platform under registration number CRD42022373345. The
study selection flowchart is in accordance with the PRISMA 2020 guideline.
RESULTS: A total of 494 articles were identified on the subject. Following
removal of 128 duplicates, 366 studies underwent title and abstract screening.
Of these, 24 papers were selected for full-text review. Among the 342 excluded
studies, the primary reasons included study design, population not exclusively
comprising follicular lymphoma patients, and inclusion of treatment-naïve
patients. Upon application of inclusion and exclusion criteria, 02 studies were
included. A proportional meta-analysis of overall response rate outcome was
conducted. Data synthesis show a low degree of heterogeneity using the
standard chi-squared test (χ2 = p > 0,05) and the I-squared test (I2 = 0%),
denoting robustness and precision. Using the GRADE approach, our data
suggest that dose intensified salvage regimens are a feasible option with a low
certainty of evidence.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Embargado

